7UE5
 
 | PANK3 complex structure with compound PZ-3741 | 分子名称: | 6-[4-({4-[(2R)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile, 6-[4-({4-[(2S)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile, MAGNESIUM ION, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-21 | 公開日 | 2023-03-29 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.63 Å) | 主引用文献 | Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem., 67, 2024
|
|
7UEV
 
 | |
7UE4
 
 | PANK3 complex structure with compound PZ-3855 | 分子名称: | 1,2-ETHANEDIOL, 1-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethan-1-one, ACETATE ION, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-21 | 公開日 | 2023-03-29 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.94 Å) | 主引用文献 | Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem., 67, 2024
|
|
7UE3
 
 | PANK3 complex structure with compound PZ-3804 | 分子名称: | 1,2-ETHANEDIOL, 6-[4-({4-[(2R)-1-hydroxypropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile, MAGNESIUM ION, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-21 | 公開日 | 2023-03-29 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.56 Å) | 主引用文献 | Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem., 67, 2024
|
|
7UEQ
 
 | PANK3 complex structure with compound PZ-4061 | 分子名称: | 1-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-[4-(dimethylamino)phenyl]ethan-1-one, MAGNESIUM ION, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-22 | 公開日 | 2023-03-29 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem., 67, 2024
|
|
7UET
 
 | PANK3 complex structure with compound PZ-4140 | 分子名称: | 1,2-ETHANEDIOL, MAGNESIUM ION, N-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}phenyl)methanesulfonamide, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-22 | 公開日 | 2023-03-29 | 最終更新日 | 2023-10-25 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Discovery of hPANK Activators with Improved Pharmacological Properties To Be Published
|
|
7UEY
 
 | PANK3 complex structure with compound PZ-4128 | 分子名称: | 1,2-ETHANEDIOL, MAGNESIUM ION, N-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}phenyl)-2-hydroxyacetamide, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-22 | 公開日 | 2023-03-29 | 最終更新日 | 2023-10-25 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | Discovery of hPANK Activators with Improved Pharmacological Properties To Be Published
|
|
7UE7
 
 | PANK3 complex structure with compound PZ-3883 | 分子名称: | 1,2-ETHANEDIOL, 6-{4-[(4-cyclopropyl-3-fluorophenyl)acetyl]piperazin-1-yl}pyridazine-3-carbonitrile, ACETATE ION, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-21 | 公開日 | 2023-03-29 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.55 Å) | 主引用文献 | Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem., 67, 2024
|
|
7UEU
 
 | |
7UEX
 
 | PANK3 complex structure with compound PZ-4127 | 分子名称: | 1,2-ETHANEDIOL, 2-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}anilino)-2-oxoethyl acetate, ACETATE ION, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-22 | 公開日 | 2023-03-29 | 最終更新日 | 2023-10-25 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Discovery of hPANK Activators with Improved Pharmacological Properties To Be Published
|
|
7UE6
 
 | PANK3 complex structure with compound PZ-3802 | 分子名称: | 1,2-ETHANEDIOL, 6-(4-{[5-fluoro-6-(propan-2-yl)pyridin-3-yl]acetyl}piperazin-1-yl)pyridazine-3-carbonitrile, ACETATE ION, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-21 | 公開日 | 2023-04-05 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.74 Å) | 主引用文献 | Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem., 67, 2024
|
|
7UEP
 
 | PANK3 complex structure with compound PZ-3860 | 分子名称: | 1,2-ETHANEDIOL, 1-[(2R)-4-(6-chloropyridazin-3-yl)-2-methylpiperazin-1-yl]-2-(4-cyclopropylphenyl)ethan-1-one, MAGNESIUM ION, ... | 著者 | White, S.W, Yun, M, Lee, R.E. | 登録日 | 2022-03-22 | 公開日 | 2023-03-29 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem., 67, 2024
|
|
7SG3
 
 | The X-ray crystal structure of the Staphylococcus aureus Fatty Acid Kinase B1 mutant A121I-A158L to 2.35 Angstrom resolution (Open form chain A, Palmitate bound) | 分子名称: | Fatty Acid Kinase B1, PALMITIC ACID | 著者 | Cuypers, M.G, Gullett, J.M, Rock, C.O, White, S.W. | 登録日 | 2021-10-04 | 公開日 | 2021-10-27 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.35 Å) | 主引用文献 | Identification of structural transitions in bacterial fatty acid binding proteins that permit ligand entry and exit at membranes. J.Biol.Chem., 298, 2022
|
|
6B3V
 
 | PANK3 complex with compound PZ-2891 | 分子名称: | 1,2-ETHANEDIOL, 6-(4-{[4-(propan-2-yl)phenyl]acetyl}piperazin-1-yl)pyridazine-3-carbonitrile, MAGNESIUM ION, ... | 著者 | White, S.W, Yun, M. | 登録日 | 2017-09-25 | 公開日 | 2018-08-29 | 最終更新日 | 2023-10-04 | 実験手法 | X-RAY DIFFRACTION (1.601 Å) | 主引用文献 | A therapeutic approach to pantothenate kinase associated neurodegeneration. Nat Commun, 9, 2018
|
|
7JFR
 
 | Auristatin bound to tubulin | 分子名称: | Auristatin, CALCIUM ION, GUANOSINE-5'-DIPHOSPHATE, ... | 著者 | Moquist, P.N, Waight, A. | 登録日 | 2020-07-17 | 公開日 | 2020-09-16 | 最終更新日 | 2023-11-15 | 実験手法 | X-RAY DIFFRACTION (2.35 Å) | 主引用文献 | Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models. Mol.Cancer Ther., 20, 2021
|
|